Fujifilm, CDI Agree $307m Acquisition
This article was originally published in PharmAsia News
Executive Summary
Fujifilm is forking out $307 million for US firm Cellular Dynamics International (CDI) in order to become "more competitive in the field of drug discovery and regenerative medicine," said Fujifilm CEO Shigetaka Komori.
You may also be interested in...
Fujifilm Promises A Shake-Up Of Regenerative Medicines Market
Fujifilm has successfully transformed its business strategy by expanding away from traditional photographic film and toward new priority business fields – significantly in regenerative medicine. Identifying health care as a key growth area, Fujifilm targets the role of being a comprehensive provider in the fields of prevention, diagnosis and treatment.
Cynata Sets Stage For Global Fujifilm Cell Therapy Deal
Cynata has inched closer to a major global partnership after signing a term sheet with Fujifilm for cell therapy technologies that has been described by analysts as a potentially transformative deal.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.